Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Teva
UBS
Harvard Business School
Colorcon
Cantor Fitzgerald
Accenture
US Department of Justice
Boehringer Ingelheim

Generated: June 20, 2018

DrugPatentWatch Database Preview

OXICONAZOLE NITRATE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Oxiconazole Nitrate, and what generic alternatives are available?

Oxiconazole Nitrate is a drug marketed by Taro Pharms and is included in one NDA.

The generic ingredient in OXICONAZOLE NITRATE is oxiconazole nitrate. There are four drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the oxiconazole nitrate profile page.
Summary for OXICONAZOLE NITRATE
Drug patent expirations by year for OXICONAZOLE NITRATE
Pharmacology for OXICONAZOLE NITRATE
Ingredient-typeAzoles
Drug ClassAzole Antifungal
Synonyms for OXICONAZOLE NITRATE
(1Z)-N-[(2,4-dichlorobenzyl)oxy]-1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethanimine nitrate
(Z)-1-(2-(2,4-Dichlorophenyl)-2-(((2,4-dichlorophenyl)oxy)imino)ethyl)-1H-imidazole mononitrate
(Z)-1-(2,4-Dichlorophenyl)-2-(1H-imidazol-1-yl)ethanone O-(2,4-dichlorobenzyl) oxime nitrate
(Z)-1-(2,4-dichlorophenyl)-N-[(2,4-dichlorophenyl)methoxy]-2-imidazol-1-yl-ethanimine
(Z)-1-[2-(2,4-Dichlorophenyl)-2-[[(2,4-dichlorophenyl)oxy]imino]ethyl]-1H-imidazole mononitrate
1-[(2Z)-2-{[(2,4-dichlorobenzyl)oxy]imino}-2-(2,4-dichlorophenyl)ethyl]-1H-imidazol-3-ium nitrate
104360-36-3
2',4'-Dichloro-2-imidazol-1-ylacetophenone (Z)-(o-(2,4-dichlorobenzyl))oxime nitrate
2',4'-Dichloro-2-imidazol-1-ylacetophenone (Z)-(O-(2,4-dichlorobenzyl)oxime), mononitrate
2',4'-dichloro-2-imidazol-1-ylacetophenone (Z)-[OO-(2,4-dichlorobenzyl)oxime] mononitrate
64211-45-6 (parent)
64211-46-7
AB2000321
AC1Q21VX
AK163176
AKOS016339564
Ambap64211-45-6
C08075
CAS-64211-46-7
CCG-40020
CHEBI:7826
CHEMBL1200836
CPD000469293
CS-7908
D00885
DSSTox_CID_25943
DSSTox_GSID_45943
DSSTox_RID_81241
DTXSID2045943
EINECS 264-730-3
Ethanone, 1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)-, O-((2,4-dichlorophenyl)methyl)oxime, (Z)-, mononitrate
Ethanone, 1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)-, o-((2,4-dichlorophenyl)methyl)oxime, nitrate, (Z)-
Ethanone, 1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)-, o-((2,4-dichlorophenyl)methyl)oxime,nitrate, (Z)-
HMS1922D18
HMS2093B21
HY-B1324
KS-5288
LS-67327
MFCD01727545
MLS001424103
MolPort-003-666-639
Myfungar
n-[(2,4-dichlorobenzyl)oxy]-1-(2,4-dichlorophenyl)-2-(1h-imidazol-1-yl)ethanimine nitrate(1:1)
NCGC00095170-01
NCGC00095170-02
NCGC00177980-03
NSC-758958
NSC758958
Oceral
Okinazole
Oxiconazole mono-nitrate (Z)-isomer
oxiconazole mononitrate, (Z)-isomer
Oxiconazole nitrate (JAN/USAN)
Oxiconazole nitrate [USAN:JAN]
Oxistat
Oxistat (TN)
Pharmakon1600-01505330
PubChem14799
Ro-13-8996/001
Ro-138996
RQ8UL4C17S
SAM001246724
SCHEMBL153416
SCHEMBL153417
Sgd 301-76
SGD-301-76
Sgd-30176
SMR000469293
SPECTRUM1505330
SR-05000002005
SR-05000002005-3
ST 813
ST-813
ST24036505
Tox21_111467
Tox21_111467_1
UNII-RQ8UL4C17S

US Patents and Regulatory Information for OXICONAZOLE NITRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro Pharms OXICONAZOLE NITRATE oxiconazole nitrate CREAM;TOPICAL 205076-001 Mar 7, 2016 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
McKinsey
AstraZeneca
Fish and Richardson
QuintilesIMS
Argus Health
Colorcon
McKesson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.